Evaluation of c-MYC status in primary acquired cholesteatoma by using fluorescence in situ hybridization technique

Otology and Neurotology

Volumn 27, Issue 5, 2006, Pages 588-591

  Ozturk, Kayhan ^a   Yildirim, Mahmut Selman ^a   Acar, Hasan ^a   Cenik, Ziya ^a   Keles, Bahar ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Aneuploidy; c MYC; Cholesteatoma; Chromosome 8; FISH; Oncogene

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; CELL PROLIFERATION; CHOLESTEATOMA; CHROMOSOME 8; CHROMOSOME 8Q; CLINICAL ARTICLE; CONTROLLED STUDY; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENE LOCATION; HUMAN; MALE; ONCOGENE C MYC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; ANEUPLOIDY; CHOLESTEATOMA, MIDDLE EAR; CHROMOSOMES, HUMAN, PAIR 8; DNA-BINDING PROTEINS; FEMALE; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; MIDDLE AGED; TRANSCRIPTION FACTORS;

EID: 33746813693     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/01.mao.0000226290.04048.d9     Document Type: Article

References (22)

1. Tokuriki M, Noda I, Saito T, et al. Gene expression analysis of human middle ear cholesteatoma using complementary DNA arrays. Laryngoscope 2003;113:808-14.
2. Chole RA, Choo MJ. Chronic otitis media, mastoiditis, and petrositis. In: Cummings CW, Fredrickson JM, Harker LA, et al. eds. Otolaryngology Head Neck Surgery. St. Louis: Mosby, 1998: 3026-46.
3. Ozturk K, Yildirim MS, Acar H, et al. Micronucleus frequency in acquired middle ear cholesteatoma. Acta Otolaryngol 2004;124:924-8.
4. Selim AG, El-Ayat G, Naase M, et al. C-myc oncoprotein expression and gene amplification in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast. Breast 2002;11:466-72.
5. Wilda M, Busch K, Klose I, et al. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus. Genes Chromosomes Cancer 2004;41:178-82.
6. Yakut T, Egeli U, Gebitekin C. Investigation of c-myc and p53 gene alterations in the tumor and surgical borderline tissues of NSCLC and effects on clinicopathologic behavior: by the FISH technique. Lung 2003;181:245-58.
7. Krecicki T, Fraczek M, Jelen M, et al. Expression of c-myc oncoprotein in laryngeal squamous cell carcinoma. Acta Otolaryngol 2004;124:634-7.
8. Holly A, Sittinger M, Bujia J. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 1995;252:366-9.
9. Wang MB, Alavi S, Engstrom M, et al. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization. Anticancer Res 1999;19:925-31.
10. Ozturk K, Acar H, Durmus E, et al. Analysis of chromosomes 8 and 17 aneuploidies in laryngeal squamous cell carcinoma by fluorescence in situ hybridization. Laryngoscope 2004;114:1005-10.
11. Yildirim MS, Ozturk K, Acar H, et al. Chromosome 8 aneuploidy in acquired cholesteatoma. Acta Otolaryngol 2003;123:372-6.
12. Kojima H, Miyazaki H, Shiwa M, et al. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length. Laryngoscope 2001;111:867-73.
13. Parisier SC, Cohen AJ, Selkin BA, et al. Acquired cholesteatoma. In: Lalwani AK, Grundfast KM eds. Pediatric Otology and Neurotology. Philadelphia: Lippincott-Raven Publishers, 1998:295-310.
14. Albino P, Kimmelman CP, Parisier SC. Cholesteatoma: A molecular and cellular puzzle. Am J Otol 1998;19:7-19.
15. Ergun S, Zheng X, Carlsoo B. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma. Am J Otol 1996;17:393-6.
16. Yetiser S, Satar B, Aydin N. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1 alpha in chronic otitis media with or without cholesteatoma. Otol Neurotol 2002;23:647-52.
17. Kojima H, Tanaka Y, Tanaka T, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 1998;124:261-4.
18. Goh EK, Lee BJ, Wang SG, et al. Expression of telomerase activity in cholesteatoma otitis media. J Laryngol Otol 2001:881-4.
19. Wabg J, Xie LY, Allan S, et al. MYC activates telomerase. Genes Dev 1998;12:1769-74.
20. Elder JT, Klein SB, Tavakkol A, et al. Growth factor and protooncogene expression in psoriasis. J Invest Dermatol 1990;95:S7-9.
21. Tadini G, Cerri A, Crosti L, et al. P53 and oncogenes expression in psoriasis. Acta Derm Venereol Suppl (Stockh) 1989;146:33-5.
22. Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999;19:1-11.